46 assets in Childhood Acute Myeloid Leukemia

Therapeutic assets addressing Childhood Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Etoposide Childhood Acute Myeloid Leukemia	Joanna Yi	P3	BBB (77)
Cytarabine Childhood Acute Myeloid Leukemia	Children's Oncology Group	P3	BBB (76)
Cyclophosphamide Childhood Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P3	BBB (72)
Methotrexate Childhood Acute Myeloid Leukemia	Children's Oncology Group	P3	BBB (72)
Busulfanum Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P3	BB (70)
Cyclosporin A Childhood Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P3	BB (70)
Idarubicin Childhood Acute Myeloid Leukemia	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P3	BB (70)
Romidepsin Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P3	BB (70)
Sirolimus Childhood Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	BB (69)
Thiotepa Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P2	BB (68)
Hydrocortisone Childhood Acute Myeloid Leukemia	Children's Oncology Group	P3	BB (66)
Melphalan Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P2	BB (65)
Mitoxantrone Childhood Acute Myeloid Leukemia	Princess Maxima Center for Pediatric Oncology	P2/3	B (63)
Ruxolitinib Childhood Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	B (62)
Clofarabine Childhood Acute Myeloid Leukemia	Princess Maxima Center for Pediatric Oncology	P2	B (61)
Sorafenib Childhood Acute Myeloid Leukemia	Children's Hospital of Soochow University	P2/3	B (61)
Azacitidine Childhood Acute Myeloid Leukemia	Children's Hospital of Soochow University	P2	B (60)
Carboplatin Childhood Acute Myeloid Leukemia	Joanna Yi	P2	B (60)
Quizartinib Childhood Acute Myeloid Leukemia	Princess Maxima Center for Pediatric Oncology	P2	B (60)
Decitabine Childhood Acute Myeloid Leukemia	Children's Hospital of Soochow University	P2	B (58)
Venetoclax Childhood Acute Myeloid Leukemia	Joanna Yi	P2	B (58)
Abatacept Recombinant Childhood Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2/3	B (57)
Cladribine Childhood Acute Myeloid Leukemia	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P2/3	B (57)
Avapritinib Childhood Acute Myeloid Leukemia	Children's Hospital of Soochow University	P2	CCC (53)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester) Childhood Acute Myeloid Leukemia	Children's Hospital of Soochow University	P2	CCC (53)
Gilteritinib Childhood Acute Myeloid Leukemia	Children's Hospital of Soochow University	P2	CCC (53)
Recombinant Human Granulocyte Colony-Stimulating Factor Childhood Acute Myeloid Leukemia	Children's Hospital of Soochow University	P2	CCC (53)
Selinexor Childhood Acute Myeloid Leukemia	The Children's Hospital of Zhejiang University School of Medicine	P2	CCC (53)
Plerixafor Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P1/2	CCC (50)
Bpx-501 T Cells Childhood Acute Myeloid Leukemia	Bellicum Pharmaceuticals	P1/2	CC (47)
Clifutinib Childhood Acute Myeloid Leukemia	Sunshine Lake Pharma Co., Ltd.	P1	CC (46)
Rimiducid Childhood Acute Myeloid Leukemia	Bellicum Pharmaceuticals	P1/2	CC (46)
Memory-Like Natural Killer Cells Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P1/2	CC (45)
Rabbit Anti-Thymocyte Globulin Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P1/2	CC (45)
Tcr Alpha Beta / Cd19+ Depleted Haploidentical Hematopoietic Progenitor Cell Graft Childhood Acute Myeloid Leukemia	Washington University School of Medicine	P1/2	CC (45)
Revumenib Childhood Acute Myeloid Leukemia	Children's Oncology Group	P1	CC (43)
Vyxeos Childhood Acute Myeloid Leukemia	Princess Maxima Center for Pediatric Oncology	P1	CC (43)
cd33*cd3 bsab Childhood Acute Myeloid Leukemia	Y-mAbs Therapeutics	P1	CC (41)
cd70-targeting car-t cells Childhood Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P1	CC (41)
cd8+ and cd4+ donor memory t-cells-expressing ha1-specific tcr Childhood Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	CC (41)
Dna, D(3'-Amino-3'-Deoxy-P-Thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-(O-(2-Hydroxy-3-((1-Oxohexadecyl)Amino)Propyl) Hydrogen Phosphorothioate) Childhood Acute Myeloid Leukemia	Children's Oncology Group	P1	CC (41)
Folr1 Car T-Cells Childhood Acute Myeloid Leukemia	Fred Hutchinson Cancer Center	P1	CC (41)
Mesna Childhood Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P1	CC (41)
Pasifolate Exatecan Childhood Acute Myeloid Leukemia	Elucida Oncology	P1	CC (41)
Crisantaspase Childhood Acute Myeloid Leukemia	Joanna Yi	Early P1	C (39)
JK500 cells Childhood Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	Early P1	NR ()